Next Financial Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-100
Closed -$7K 2067
2018
Q3
$7K Buy
+100
New +$7.18K ﹤0.01% 1102
2017
Q4
Sell
-100
Closed -$7K 1085
2017
Q3
$7K Hold
100
﹤0.01% 1337
2017
Q2
$6K Sell
100
-312
-76% -$18.7K ﹤0.01% 1504
2017
Q1
$25K Sell
412
-582
-59% -$34K 0.01% 964
2016
Q4
$56K Buy
994
+76
+8% +$4.38K 0.01% 916
2016
Q3
$57K Buy
918
+206
+29% +$13.5K 0.01% 897
2016
Q2
$45K Buy
712
+200
+39% +$12.6K 0.01% 689
2016
Q1
$30K Sell
512
-88
-15% -$5.38K 0.01% 785
2015
Q4
$41K Hold
600
0.02% 675
2015
Q3
$39K Sell
600
-341
-36% -$26.5K 0.01% 711
2015
Q2
$73K Hold
941
0.03% 560
2015
Q1
$71K Hold
941
0.02% 569
2014
Q4
$63K Sell
941
-124
-12% -$8.26K 0.02% 582
2014
Q3
$68K Buy
+1,065
New +$65.8K 0.01% 808

Other funds holding PJP

Next Financial Group's PJP Position: Q4 2018 in Review

Next Financial Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2018, closing a stake of 100 shares — an estimated $7K sold.

Next Financial Group first reported a position in PJP in Q3 2014 and held it in 14 quarters. The position peaked at $73K in Q2 2015. 91 funds tracked by Wall St. Rank hold PJP as of Q4 2018.

  • Next Financial Group reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2018 after selling out during the quarter.
  • Next Financial Group sold 100 Invesco Pharmaceuticals ETF shares in Q4 2018, an estimated $7K.
  • Next Financial Group first reported a position in Invesco Pharmaceuticals ETF in Q3 2014 and held it in 14 quarters.
  • Next Financial Group's Invesco Pharmaceuticals ETF position peaked at $73K in Q2 2015.
  • 91 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2018.

Based on Next Financial Group's 13F filing for Q4 2018, filed 11 Feb 2019.